Abstract
For some time an assessment of the Quality of pharmaceutical inspections particularly in China has yet to be addressed. This study examines records of inspections that took place in China and India in 2019. Inspection scores in China and India were below average in 2019 which leads one to believe there needs to be an increase in the quality of inspections in these locations leading to a positive outcome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
